Dir, Access International

Band

Level 6

Job Description Summary

Access Directors are dedicated to co-developing innovative and winning market access strategies optimizing the payer value proposition and access-relevant evidence packages for assets in partnership with cross- functional teams.
They develop and implement transformative access solutions serving strategic disease areas (DAs) and maximizing IM assets with focus on our priority geographic markets (CN DE JP) major HTA archetypes (e.g. UK/CAN) and Budget Impact archetypes (e.g. Italy/Spain) needs and feasibility. Access Directors
Represent access with internal partners and external stakeholders. Internally drive vision inspire and provide leadership throughout the Access community (International Regions Countries) and with key partners (CPS/International Development Biomedical Research Operations S&G Regions and Countries). Externally represent Novartis in appropriate fora and organizations to drive the Novartis strategic access agenda.
With International TA develop and deliver all aspects of access strategy and execution for compounds/brands across the R-D-C continuum.
Collaborate and partner with TAs Medical Affairs Development and Biomedical Research to enhance the value proposition access strategy and access-relevant evidence packages. Ensure access landscaping and payer evidence requirements are built into TPPs clinical development plans integrated product strategies indication sequencing/asset maximization.
Enable asset strategy to translate science into payer and HCS value propositions and solutions securing access affordability and contribute to wide scale patient access and efficiencies at scale.
Create the international pricing strategy and support guidance.
Generate payer negotiation strategy upskill and prepare countries for their payer negotiations.
Ensure the appropriate and timely access inputs into IEPs IPS asset maximization incl. indication sequencing.
Create collaborative partnerships internally and externally to break down silos partner across the value chain and shape the future of healthcare and markets.
Manage resource requirements to address asset/DA priorities.

Job Description

Key Responsibilities:

• Develop the international integrated product access strategy (IPAS) to deliver product differentiation most relevant to payers (e.g. well-defined target population clinical endpoints comparators outcome measures utility instruments Health Economics data) patients and HCS stakeholders worldwide. Ensure that at launch Novartis brands are supported by a robust payer value proposition particularly featuring core elements; Value for money story strong value evidence package and a pricing strategy maximizing the lifetime value of the brand (including existing and future evidence to justify price) and the reputation of Novartis.
• Ensure access team develops and represents expert value evidence input into TPPs clinical programs (including IEPs) BD&Ls and develop any additional non-registration evidence to meet the needs of medical experts and institutions involved in reimbursement & access decisions for key geographies.
• Collaborate with the HEOR & PCO team to ensure full integration of adequate HEOR/evidence deliverables in high quality cross-franchise strategy. Ensure appropriate focus on priority markets needs into overall strategy.
• Determine payer evidence requirements risks/opportunities in the access landscape and create compelling access strategy with the TA and provide the access toolbox to share with priority markets (CN DE JP) major HTA archetypes (e.g. UK/CAN) and Budget Impact archetypes (e.g. Italy/Spain)
• Ensure appropriate and timely access input into BD&Ls asset maximization incl. indication sequencing. Maximize value of IM assets by creating and executing together with TAs & pricing team winning pricing strategies global pricing guidance incl. MEAs PSPs rigorous international pricing governance.
• Stay abreast of internal and external developments trends and other dynamics that affect the wider health policy and access domains as well as of relevant scientific clinical and commercial developments.
• Collaborate with S&G and Development to drive consistent and access-optimal approaches to product shaping value propositions and HCS value creation. Analyze and anticipate changes in priority international markets (CN DE JP) major HTA archetypes (e.g. UK/CAN) and Budget Impact archetypes (e.g. Italy/Spain) to model future expenditures and project critical market access value of medicines to HCS decision-makers with focus on international forums and publications in collaboration with international or regional policy groups.
• Manage Access community and budgets. Effectively work in matrix balancing cross-functional perspectives and alignment with business priorities against flexible resourcing.

Essential requirements:

• 5 years of experience in market access roles
• 2 years global or ex-US regional experience
• Experience working early in drug development lifecycle
• Product launch experience
• Cross functional and matrix influential experience across a team of multiple stakeholders
• Experience in driving commercial strategy driven through access or HEOR or pricing expertise

Desirable requirements:

Skills Desired

Access And Reimbursement Strategy Access And Reimbursement Strategy Agility Analytical Skill Analytical Thinking Cross-Functional Collaboration Customer-Centric Mindset Employee Development Finance Go-To-Market Strategy Healthcare Sector Understanding Health Economics Health Policy Health Technology Assessment (HTA) Influencing Skills Innovation Inspirational Leadership Lcm Strategy Market Access Strategy Negotiation Skills People Management Pricing Strategy Process Management Product Launches Public Affairs 7 more